# Strattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified (ADHD NOS)

> **NCT00181766** · PHASE4 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 45 (actual)

## Conditions studied

- ADHD NOS

## Interventions

- **DRUG:** Strattera (atomoxetine)

## Key facts

- **NCT ID:** NCT00181766
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2019-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00181766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00181766, "Strattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified (ADHD NOS)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00181766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*